The p53-dependent activation of the FAS death receptor pathway by nutlin-3a plays a significant role in cell killing in cisplatin-resistant testicular carcinoma cells [158], whilst DR5 is important in breast cancer and melanoma cell lines [159, 160]. Here, TP53 is linked to breast cancer.